IRFC Stake Sale, Lupin FDA Approval, and Infrastructure Contracts Drive Market Focus

Indian equities showed positive momentum with key stocks like Indian Railway Finance Corporation (IRFC), Lupin, HG Infra Engineering, Rail Vikas Nigam (RVNL), and Waaree Energies in focus. The government plans to sell a 2% stake in IRFC via an Offer for Sale but will not exercise the additional greenshoe option after weak subscription. HG Infra secured a Rs 1,582 crore NHAI project, while Waaree Energies won a 300 MW wind power contract. Lupin received US FDA approval for a new drug, and RVNL secured a Rs 270 crore railway order. Market analysts noted volatility and potential downside risks despite gains.